Gastrointestinal Dysbiosis: What it is and How to Recognize it g
Transcription
Gastrointestinal Dysbiosis: What it is and How to Recognize it g
Gastrointestinal Dysbiosis: What it is and How to Recognize g it Gerard E. Mullin, MD Advanced Practice Module: Restoring Gastrointestinal Equilibrium Austin, TX February 2010 ©2010, The Institute for Functional Medicine Learning Objectives • • • Be able to recognize the signs and symptoms y p associated with dysbiosis y to help in the proper diagnosis of this condition E l Evaluate dysbiosis d bi i using i conventional i l and unconventional laboratory testing so as to be able to treat appropriately Evaluate patients for suspected parasitic infections so as to appropriately diagnose these conditions ©2010, The Institute for Functional Medicine Dysbiosis Dysbiosis (also called dysbacteriosis) is the condition of having microbial imbalances on or within the body. Dysbiosis is most prominent in the digestive tract or on the skin but can also occur on any exposed surface or mucous membrane b such h as th the vagina, i lungs, nose, sinuses, ears, nails, or eyes. ©2010, The Institute for Functional Medicine Dysbiosis: History ©2010, The Institute for Functional Medicine Dysbiosis: History • • • • Concept consolidated by Metchnikoff in 1908 119 Medline articles indexed by “dysbiosis” as of November 2008 Other related terms: • Dysbacteriosis • Autointoxication • Dermatitis-arthritis syndrome • Short bowel syndrome • Small S ll intestinal i t ti l bacterial b t i l overgrowth th (SIBO): (SIBO) IBS IBS, fibromyalgia • Mucosal colonization • Subclinical infection Some controversy still exists in the medical literature ©2010, The Institute for Functional Medicine Dysbiosis is not so much about the microbe as it is about b t the th effect ff t off that th t microbe on a susceptible host; i.e., it is about the relationship between host and microbe. ©2010, The Institute for Functional Medicine Dysbiosis We are not looking for classic “infection” • • • Determine if imbalances in the gut microbiota may be exacerbating inflammation and the patient’s symptoms Dysbiosis in one patient may present with d dermatitis; titi the th same microbial i bi l imbalance i b l in i another patient can present as peripheral neuropathy or inflammatory arthritis. Often what we find when working with autoimmune/inflammatory patients is that they y are having gap pathogenic g inflammatory y response to a nonpathogenic microbe ©2010, The Institute for Functional Medicine Subtypes of Dysbiosis • Insufficiency ff dysbiosis: Lack off beneficial f microbes • Bacterial overgrowth: Colonic microbes in the small • • • • bowel Immunosuppressive dysbiosis: Microbes produce toxins that suppress immune function [e.g., the pp mycotoxin y produced p by y immunosuppressive Candida albicans is called gliotoxin] Hypersensitivity/allergic dysbiosis: Some people have an exaggerated immune response to otherwise “normal” yeast and bacteria Inflammatory dysbiosis: Causes reactive arthritis P Parasites: it A Amoebas, b cysts, t protozoa, t and d other th parasites ©2010, The Institute for Functional Medicine The Many Faces of Dysbiosis ©2010, The Institute for Functional Medicine The Many faces of Dysbiosis Toxins Microbial Antigens D-Lactic Acidosis Mitochondrial Inhibitors Proinflammatory Cytokines Neuroendocrine Dysregulation Autoantibodies False NTs ©2010, The Institute for Functional Medicine Immune Complex Deposition Dysbiosis: Assessment Clinical assessments: • Swab and culture / DNA pprobe / PCR • Antigen tests (e.g., stool H. pylori antigen) • Breath hydrogen/methane for SIBO • Jejunal aspiration – fungus and SIBO • Stool St l tests t t – speciality i lit labs l b • Response to treatment: objective markers (e.g., ESR, CRP, disease activity indexes) ©2010, The Institute for Functional Medicine Flora Balance Dysbiosis: • Broad-spectrum antibiotics • Chronic Ch i maldigestion ldi ti (including (i l di PPIs) PPI ) • Chronic constipation • Stress suppresses lactobacilli lactobacilli, bifidobacteria, and sIgA Catecholamines stimulate growth of gram-negative organisms (yersinia, (yersinia pseudomonas) 45–50% of total body production of NE occurs in mesenteric organs Anger A or ffear iincreases Bacteroides B t id fragilis f ili ©2010, The Institute for Functional Medicine Flora Balance Beneficial Bacteria: • Digestion • Synthesis of vitamins • Enterohepatic recirculation of hormones • Acidification • Prevention of colonization by pathogens • Oral tolerance • SCFA production ©2010, The Institute for Functional Medicine Action of BetaBeta-glucuronidase Gl Glucuronidation id ti off estrogen in liver Conjugated estrogen excreted in bile Re-absorption leads to increased estrogen circulation Cleaves glucuronide Release of free estrogen +++ Beta-Glucuronidase Excreted in Stool ©2010, The Institute for Functional Medicine Beta--glucuronidase Beta • • Bacterial enzyme that acts to deconjugate glucuronides of toxic molecules, rendering th them active ti again i – recirculation i l ti off carcinogens, hormones, etc. Inducible enzyme, y , upregulated p g by: y • • • • Diet high in meat fat Alkaline pH of the gut Lower activity L ti it with ith increased i d fiber, fib lactobacilli, oranges Calcium-d-glucarate g inhibits enzyme y activity ©2010, The Institute for Functional Medicine Stool Microbiology ©2010, The Institute for Functional Medicine Candida albicans and Normal Flora • • • • Candida is commensal at low levels A lower gut pH (lactic acid and SCFAs) inhibits Candida growth Candida overgrowth lowers mucosal immunity by splitting sIgA molecules C did mannans (polysaccharides) Candida ( l h id ) impair host immune response ©2010, The Institute for Functional Medicine Yeast Overgrowth • • Microscopy and culture Organic acids • Arabinose • Citramalic acid • Tartaric acid • BetaKetoGlutaric acid Fonseca C, et al. FEBS J. 2007 Jul;274(14):3589-600, and Based on Clinical Experience ©2010, The Institute for Functional Medicine Common Symptoms of Yeast Overgrowth • • • • • • • • Fatigue Poor Memory, “Spacey” Insomnia or Hypersomnia Anxiety Mood Swings Muscle and Joint Aches and Pains Alcohol Intolerance Pruritus ©2010, The Institute for Functional Medicine XXX “Pillsbury Doughboy” ©2010, The Institute for Functional Medicine Infectious Diarrhea ©2010, The Institute for Functional Medicine Which Condition is the Most Common Cause of Bacterial Diarrhea? A. C. difficile infection B. Salmonella C. Shigella D. Campylobacter py ©2010, The Institute for Functional Medicine C. difficile ©2010, The Institute for Functional Medicine Infectious Diarrhea: C. difficile Anaerobic, spore-forming, gram + bacteria associated with diarrhea and colitis liti after ft antibiotic tibi ti use • More common than previously thought • Presentation not always “sick” patient • Chronic and recurrent infections common • Need to test for toxins A and B ©2010, The Institute for Functional Medicine Clinical Pearl • • • Some of those infected with C. difficile may y have recurrent mild to moderate diarrhea that may resemble IBS C. difficile may also present as a condition di i indistinguishable i di i i h bl from f IBD with cramps, diarrhea, urgency, mucus, and blood So unless it is diagnosed, C. difficile may be misdiagnosed as IBS or IBD ©2010, The Institute for Functional Medicine Common Symptoms of Parasites • • • • • • • Diarrhea or constipation Abdominal pain Belching, flatulence, distention Anorexia nausea Anorexia, nausea, chills chills, fever, fever headache, rash, pruritus Blood or mucous in stools Intractable fatigue Weight loss ©2010, The Institute for Functional Medicine Parasite Detection Detection D t ti rates t are a ffunction ti of: f • Specimen collection and handling • Number and kind of specimens examined • Concentration procedures • Staining procedures • Macroscopic and microscopic examination techniques • Quality of training, frequency of practice, and dedication of laboratory personnel ©2010, The Institute for Functional Medicine Common Parasites • • • • • A recentt study t d b by a commercial i l laboratory revealed 23.5% of clinical samples tested positive for at least one parasite it (3,223/13,857) (3 223/13 857) Blastocystis hominis (12.5%) Di Dientamoeba b ffragilis ili (3.8%) (3 8%) Entamoeba spp. (3.4%) Endolimax nana (2.2%) Giardia lamblia (0.7%) Courtesy of P. Hanaway ©2010, The Institute for Functional Medicine Parasitology R Report t ©2010, The Institute for Functional Medicine Secondary Investigations Microbiology, Parasitology, Immunology • • • • • Culture Mi Microscopy EIA testing DNA testing Ab’s ©2010, The Institute for Functional Medicine Small Intestinal Bacterial Overgrowth A frequently overlooked contributor in common disorders: • IBS 78% of patients tested positive 48% of successfully treated patients no longer met Rome criteria for IBS • Fibromyalgia and CFS 78% and 77% of subjects, respectively, have SIBO Both disorders overlap with IBS ©2010, The Institute for Functional Medicine Small Intestinal Bacterial Overgrowth • Dysmotility syndromes • Systemic disease disease, e e.g., g DM DM, scleroderma • Prior intestinal surgery • Strictures of the small intestine • • • • Jejunal diverticulosis Crohn’s disease Symptoms in celiac disease, disease despite no gluten Aging • 64% % of individuals > 75 y years with chronic diarrhea • SIBO is most common cause of malabsorption in the elderly ©2010, The Institute for Functional Medicine Natural Defense Factors that Prevent SIBO are Shown Within the Circles Stomach Absorption Acid Enzyme & Pancreas Bile Duodenum Motility Immunity y Jejunum Ileocecal valve ©2010, The Institute for Functional Medicine Ileum Causes of SIBO • • • • • • • Achlorhydria Motor abnormalities Scleroderma Intestinal pseudoobstruction Diabetic enteropathy Vagotomy Abnormal communication between colon and small bowel ©2010, The Institute for Functional Medicine • • • • • • Fistulas between colon and small bowel Resection of ileocecal valve Structural abnormalities Surgical loops (Billroth II, II entero-entero anastomosis) Duodenal or jejunal diverticula Partial obstruction of small bowel (stricture, adhesions, tumors) Flora in SIBO • Composition varies: • • Coliforms and strict anaerobes Concentrations always higher than normal (>105/mL) Bacteria that are normal in the colon may produce deleterious effects within the delicate environment of the small intestine … ©2010, The Institute for Functional Medicine Clinical Consequences off Bacterial B t i l Overgrowth O th Gas and bloating bloating, abdominal discomfort • Bacterial fermentation of intraluminal sugars g Classic SIBO syndrome: • Megaloblastic g anemia (B ( 12 deficiency) • Weight loss and diarrhea secondary to fat f malabsorption l b i ©2010, The Institute for Functional Medicine Distribution of Intestinal Bacterial Flora in Normal Gut and in SIBO Origin of gas/bloating of IBS patients with SIBO Lin, H. C. JAMA 2004;292:852-858. ©2010, The Institute for Functional Medicine SIBO Diagnosis: Breath Testing 70 • • Indirect test Measures fermentation: H2 and CH4 Transit too fast Transit: gives false positive Substrate: • • Glucose spec > sens Lactulose sens > spec ©2010, The Institute for Functional Medicine Hyddrogen (ppm) • • 60 50 40 30 20 10 0 15 30 45 60 75 90 105 120 135 150 165 180 Time (in minutes) Normal SIBO A Breakthrough: Diagnosing SIBO • • Clues: Bloating g after carbohydrate meals Conventional testing g (breath hydrogen) HYDROGEN BREATH TEST 200 157 150 ppmH2 • 116 116 112 133 79 100 50 2 2 18 30 45 0 Specialized p testing: g urinary organic acids (indican, D-lactate) ©2010, The Institute for Functional Medicine Breath Samples 137 156 Mechanisms of Fat Malabsorption in SIBO 1) Bacteria deconjugate bile salts to free bil acids bile id Mucosal damage malabsorption (also disaccharidase and peptidase deficiencies) Low bile salts leads to impaired micelle formation fat malabsorption and steatorrhea 2) Pseudomembrane mechanical interference with absorption ©2010, The Institute for Functional Medicine Malnutrition in SIBO • Unabsorbed U b b d fatty f tt acids id may form f insoluble i l bl soaps with minerals such as Ca and Mg • Osteomalacia, night blindness, hypocalcemic tetany metabolic bone disease possible tetany, • Vitamin B12 deficiency • Bacteria utilize B12 and detach B12 from intrinsic • factor Serum folate usually normal or elevated • Hypoproteinemia yp p • Protein-losing enteropathy or protein malabsorption • Bacterial metabolism of proteins to ammonia and fatty acids • Iron deficiency anemia (rare) ©2010, The Institute for Functional Medicine Causes of Digestive Disease: SIBO Etiologies: • Achlorhydria • Hypochlorhydria H hl h d i • PPIs • Stasis – dysmotility • Malnutrition • Collagen vascular disease • Immune deficiency ©2010, The Institute for Functional Medicine Consequences: • Carbohydrate/fiber intolerance • Bloating after meals • Iron, vitamin D, and B12 deficiency • Fat malabsorption • Enteropathy • Food F d allergies ll i • Systemic inflammation • Autonomic dysfunction Case Study: Digestive Insufficiences Insufficiences, IBS, Malnutrition, Dysbiosis Gerard E. Mullin, MD Faculty, The Institute for Functional Medicine Advanced Practice Module: Restoring Gastrointestinal Equilibrium Austin, TX February 2010 ©2010, The Institute for Functional Medicine Learning Objectives • • • • • Apply the Functional Medicine Matrix Model™ to complex clinical issues Decipher an integrative 5R action plan for patients with IBS Evaluate problems and implement practical solutions in a logical manner Apply pp y nutritional and lifestyle y interventions to improve patient outcomes Systematically assess response to the treatment plan ©2010, The Institute for Functional Medicine Case Presentation • 42-year-old female with longstanding IBS and Scleroderma presents with weight loss, failure to thrive, and diarrhea • • • IBS since traveling to Mexico 10 years ago Works as a literary manager-travels internationally Scleroderma for 12 years 2000 – Went through a divorce, IBS worsened, improved after psychotherapy 2005 – moved locations, IBS flared 2008 – Diarrhea 5 5–6x/d, 6x/d loose stool, stool bloating, bloating malodorous stools after fatty meals ©2010, The Institute for Functional Medicine Case Presentation • • • • • • • ROS: Heartburn on occasions occasions, “low energy”, listlessness, mental lethargy PMHx: depression p FHx: Mother depression, 80; father; 82, Alzheimer’s disease, no siblings Meds: None Supplements: None Di t Wh Diet: Whole l foods f d as much h as possible ibl Soc.: Divorced-remarried, 2 children – 10,12 years old, high high-stress stress job as literary manager, nonsmoker, good relationships ©2010, The Institute for Functional Medicine Case Presentation • • • • • • Self-care, beliefs: Spiritual – religious, holistic minded, cannot exercise-fatigue Objective data: BP is 83/61 83/61, pulse 115 115, weight 95, BMI of 15.3 She has temporal wasting; She has scleroderma-like features Her lungs are clear; she does have wasting in the subscapular area and sternocleidomastoid area On cardiac exam, S1 and S2 are heard throughout without murmurs, gallops or rubs Abdomen is thin, scaphoid; exam is benign ©2010, The Institute for Functional Medicine Case Presentation • • Extremities are wasted She is able to ambulate up and down f freely l • Questions: • • • • What are the underlying etiologies/ pathophysiologies? What are the antecedents/triggers/mediators? Use the Matrix to organize the case history Once we give you more data, data you will be asked to formulate your treatment plan ©2010, The Institute for Functional Medicine FUNCTIONAL MEDICINE MATRIX MODEL™ Immune Surveillance and Inflammatory Process Oxidative/Reductive Homeodynamics IBS OXIDATIVE STRESS FATIGUE BRAIN FOG FATIGUE, Digestion and Absorption Detoxification and Biotransformatio CAFFEINE ANTIDEPRESSANTS The Patient’s Story Retold IBS Antecedents HYPOCHLORHYDRIA ? FAT MALABSORPTION Hormone and Neurotransmitter Regulation ((Predisposing) ed spos g) FAMILY HISTORY Structural and Membrane I Integrity i LEAKY GUT FOOD ALLERGIES?? Nutrition Status Triggering gg g Events HPA AXIS FATIGUE (Activation) INFECTION FOOD POISIONING STRESS!! TRAVEL JOB Exercise Sleep Beliefs & Self-Care NONE 7-8 HRS RELIGIOUS Psychological and Spiritual Equilibrium DEPRESSION Relationships BMI 15.1 LOW! Albumin 3 3.9 9 g/dL Date: ____ Name: ___________________ Age _____ Sex______ Diagnoses: ____________________________________________ ©2010, The Institute for Functional Medicine SATISFACTORY ©2008 The Institute for Functional Medicine What tests would you order to assess her case? ©2010, The Institute for Functional Medicine Where Would You Begin? • • • • • Digestion/Absorption I t ti l Permeability Intestinal P bilit Gut Microbiota/Dysbiosis y Inflammation/Immune Nervous System ©2010, The Institute for Functional Medicine Digestion/Absorption Lab assessment: • C CBC/diff C/d • • • • • • • WBC 7.1 H/H 9.7/28.8 (MCV 89) RDW 20.1 (HIGH) CMP-lipids nl chol 124 25-OH D 28 ng/mL Thyroid hormone TSH 0.2 Abnl ©2010, The Institute for Functional Medicine • • • • Food allergy panel: multiple allergies – Stool O&P (-) Celiac panel (-) Yeast Ab panel (+) Digestion/Absorption D Xylose Test D-Xylose COMPONENT TEXT *** TIME POST DOSE (BLOOD) DOSE XYLOSE BLOOD XYLOSE, BLOOD, 1 HRPOST *** COMPONENT REMARK *** ©2010, The Institute for Functional Medicine 1 HOUR 11 11:47 47 25 g 47.0 47 0 mg/dL Reference Range: 25 GM DOSE: 29-72 5 GM DOSE: 8-28 Digestion/Absorption • • • • • • Organic Acids - indican, arabinitol elevated Low WBC zinc Serum B12 212 pg pg/mL Methylmalonic acid, serum 445 nmol/L (87-318) RBC folate WNL RBC magnesium low ©2010, The Institute for Functional Medicine Digestion/Absorption pH = 5 SURG PATH REPORT COLLECTION DATE/TIME: 09/23/2008 00:00 1st Specimen collected on 09/23/2008 Accessioned on 09/24/2008 at 09:51 a FINAL DIAGNOSIS ----------- Pathologist: Elizabeth Montgomery, Montgomery M.D. MD 1. 2. 3. SMALL BOWEL (BIOPSY): DUODENAL MUCOSANONDIAGNOSTIC STOMACH (BIOPSY OF ANTRUM): ANTRAL MUCOSA WITH MILDCHRONIC INFLAMMATION. NO HELICOBACTER PYLORI ORGANISMS 3. GASTRIC BODY (BIOPSY): OXYNTIC MUCOSA WITH MILD CHRONIC INFLAMMATION. NO HELICOBACTER PYLORI ORGANISMS ©2010, The Institute for Functional Medicine Digestion/Absorption pH = 5 4. GE JUNCTION (BIOPSY): CARDIAC MUCOSA WITH CHRONIC INFLAMMATION INFLAMMATION. NO GOBLET CELLS CHARACTERISTIC OF BARRETT MUCOSA OF THE DISTINCTIVE TYPE ARE SEEN. NO HELICOBACTER PYLORI ORGANISMS ARE IDENTIFIED ON DIFF-QUIK STAIN.. Note: PAS/AB stains were reviewed for each part. Reported by: The Johns Hopkins Hospital, Surgical Pathology 401 N. Broadway, Baltimore, MD 21231 Tel: 410-955-3580 Final Report Signed on 09/26/2008 at 04:39 pm ©2010, The Institute for Functional Medicine Digestion/Absorption Gastrin 325 pg/mL (<101) * Intrinsic t s c Factor acto b blocking oc g AB NEGATIVE G Gastric parietal cell AB, ELISA 12.1 U* Reference Range NEGATIVE EQUIVOCAL POSITIVE ©2010, The Institute for Functional Medicine <= 20.0 20.1–24.9 >= 25.0 25 0 Intestinal Permeability ©2010, The Institute for Functional Medicine Food Allergy Profile ©2010, The Institute for Functional Medicine Gut Microbes Gastric Aspirate FLUID, MISC SPECIMEN: 49 49-4L0231 4L0231 COLLECTION DATE/TIME: 09/23/2008 00:00 Specimen descriptor: FLUID MISC:(SMALL BOWEL) TEST: FUNGAL CULT,MICROSCO COMPONENT: FUNGAL MICRO EXAM NO FUNGUS SEEN BY POTASSIUM HYDROXIDE; Result finalized: 09/24/2008 09:53:05 ©2010, The Institute for Functional Medicine Gut Microbes Gastric Aspirate TEST: FUNGAL CULT, MICROSCO COMPONENT: FUNGAL CULTURE POSITIVE AT 2 DAYS ORG 1: 1 CANDIDA ALBICANS Result finalized: 09/25/2008 12:47:45 Test performed by: Johns Hopkins Medical Labs Meyer B1-100 600 North Wolfe Street Baltimore, MD. 21287 ©2010, The Institute for Functional Medicine SIBO ©2010, The Institute for Functional Medicine Immune/Inflammatory Adrenal Stress Index Salivary Cortisol Morning Noon Evening Midnight 4.23 8.12 10.89 7.24 S li Salivary DHEA 1.32 ©2010, The Institute for Functional Medicine 5–23 nmol/L 1.8–11.0 nmol/L 1.0–6.5 nmol/L 0.75–4.7 nmol/L 0.75–2.5 nmol/L Nervous System • • • • Depression Brain Fog Low B12 status Low RBC Magnesium ©2010, The Institute for Functional Medicine What is your assessment? ©2010, The Institute for Functional Medicine Assessment • • • • Dysbiosis D bi i • Small Intestinal Bacterial Overgrowth • Yeast Overgrowth • IgG Food Sensitivities Hormonal Imbalances • HPA Axis Dsyfunction • Adrenal Fatigue Nutritional Imbalances • Zinc, Vitamin D Insufficiency Hypochlorhydria ©2010, The Institute for Functional Medicine What is your treatment plan? 5 R’s Rs • Remove • Replace • Reinoculate • Repair • Re-Balance ©2010, The Institute for Functional Medicine What is your treatment plan? 5 R’s Rs • Remove the bugs! (parasites, SIBO allergens) SIBO, • Replace (HCl, enzymes) • Reinoculate R i l t (Flora) (Fl ) • Repair (glutamine, Zn-carnosine) • Re-Balance (mind-body: Yoga) ©2010, The Institute for Functional Medicine Remove/Replace • • • • • Elimination diet Botanicals for SIBO w/garlic, oregano oil oil, berberine Antifungal therapy HCl Enzymes ©2010, The Institute for Functional Medicine Causes of Digestive Disease Small S a Intestinal es a Bacterial ac e a O Overgrowth ego Etiologies Consequences • • • • • • • • • CHO/fiber intolerance • • • • • Fat malabsorption • Achlorhydria Hypochlorhydria PPI’s PPI s Stasis-dysmotility Malnutrition Collagen Vascular Disease Immune deficiency ©2010, The Institute for Functional Medicine Bloating after meals Iron, vitamin D and B12 deficiency Enteropathy Food Allergies Systemic inflammation Autonomic dysfunction Food Elimination Based on IgG Antibodies in Irritable Bowel Syndrome: A Randomized Controlled Trial P < 0.001 0 001 Atkinson W, et al. Gut. 2004;53:1459-1464. ©2010, The Institute for Functional Medicine Reinolculate/Repair • • • • • Anti-inflammatory medical food Pre-/probiotics Calcium/magnesium Vitamin D3 (DRI 1000 IU/d) CoQ10 200 mg/d • • • • • Betaine HCl w/meals Zinc citrate MVI, SL B12 dots Aloe-glutamine supplement Full-spectrum Full spectrum light ©2010, The Institute for Functional Medicine Comparative Effects of a Bifidobacterium, a Lactobacillus, and Placebo on Composite Score (Pain, Bl ti Bloating, etc.) t ) in i IBS over an 8-week 8 kT Treatment t t Period P i d O’Mahony L, et al. Gastroenterology. 2005;128(3):541-551. ©2010, The Institute for Functional Medicine Rebalance IBS Pathophysiology Current Opinion in Gastroenterology. 2006;22(2):128-135. ©2010, The Institute for Functional Medicine Rebalance IBS Pathophysiology • • • • • • Yoga Light therapy Less international traveling g Psychological counseling CBT Ashwagandha, 5-HTP, light exercise Current Opinion in Gastroenterology. 2006;22(2):128-135. ©2010, The Institute for Functional Medicine Diet Then Advance Diet to include prebiotics • FOS-containingg foods: Asparagus, p g Jerusalem artichokes, onions, leeks • Cruciferous vegetables vs. indole-3-carbinol • Mediterranean M dit diet: di t • Rich in green, leafy vegetables • Whole grains • High in fish, poultry • Olive oil as essential fattyy acid base ©2010, The Institute for Functional Medicine Follow-up • • • • 6 weeks: Less diarrhea, less depressed, more energy energy, sleeping better, better BMI 17 17.2 2 8 weeks: 70% better, more energy 12 weeks: BMI 18 18.3, 3 no fatigue fatigue, walking 26 weeks: 90% better, minimal diarrhea, more energy energy, no fatigue ©2010, The Institute for Functional Medicine Current Thought Process Future Outlook Individual Conditions SIBO Overlap Fibromyalgia IC RLS SIBO Pi-IBS Pi IBS FM, IC, RLS… CFS IBS ©2010, The Institute for Functional Medicine IBS SIBO Pi-IBS Take Home Sticky Points • • • • • Dysbiosis is an imbalance in the commensal p population p of flora Dysbiosis has deleterious consequences both in the gut and systemically i ll if left l f untreated d Suspect SIBO in patients w/ IBS Treat Candida overgrowth Reinnoculate w/ Probiotics ©2010, The Institute for Functional Medicine • The practice Th ti off medicine di i is i an art, t nott a trade; a calling, not a business; a calling in which your heart will be exercised equally with i h your head. h d Often Of the h best b part off your work will have nothing to do with potions and powders, but with the exercise of an influence of the strong upon the weak, of the righteous upon the wicked, of the wise upon the foolish. ~ Sir William Osler, The Three Great Lessons of Life ©2010, The Institute for Functional Medicine